Merck
MRK
#49
Rank
A$425.07 B
Marketcap
A$171.93
Share price
-1.03%
Change (1 day)
41.10%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): A$11.23

According to Merck's latest financial reports the company's current EPS (TTM) is A$10.35. an increase over its 2024 EPS that were of A$9.57.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025A$10.317.71%
2024A$9.574308.46%
2023A$0.22-97.32%
2022A$8.1110.92%
2021A$7.3184.68%
2020A$3.96-27.2%
2019A$5.4463.44%
2018A$3.33151.11%
2017A$1.33-54.58%
2016A$2.9230.21%
2015A$2.24-61.99%
2014A$5.90180.51%
2013A$2.10-31.82%
2012A$3.086.62%
2011A$2.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.77 52.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.20-1.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.93-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.31-48.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.60 214.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.29 96.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.92-71.75%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$4.90-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.34-48.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$1.76-83.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel